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ABSTRACT  
 
There are limited studies completed in the East African region to assess barriers to 
adherence with amblyopia treatment and outcomes of this treatment. Our study aims to 
identify factors which are associated with higher adherence in amblyopia treatment. 
Institutional Review Board (IRB) approval was obtained and a hospital-based 
retrospective and prospective observational study was performed at the pediatric 
ophthalmology clinic of Menelik II Referral Hospital in Addis Ababa, Ethiopia from 
March 2015 to June 2015. Included in the study were Ethiopian children, between the 
ages of 4 and 8, with a clinical diagnosis of amblyopia defined as interocular acuity 
difference of at least 0.2 logMAR. We collected demographic and clinical data from 
charts. Parents were asked to estimate the number of hours they were able to administer 
patching in the past week and fill out a brief questionnaire addressing adherence, social 
stigma, and adverse effects associated with patching. Questions addressing parents’ basic 
knowledge of amblyopia and its treatment were also included in the questionnaire. 
Fifty-three patients (25 male, 28 female) of mean age 6.4 + 1.3 years participated. Forty-
one (77.3%) of patients were residents of the capital, Addis Ababa, and 73.6% spoke 
Amharic, the national language. Amblyopia was associated with strabismus (n=36), 
anisometropia (n=6) and combined mechanism (n=11). Mean duration of treatment was 
19 months. Approximately one-third of the parents (28%) were found to be non-adherent 
to the amblyopia treatment. Adherence was associated with parental educational level (p= 
0.003) and residual amblyopia (p=0.001). Only 23.4% of patients achieved residual 
amblyopia of 0.19 logMAR units or less. The main factor affecting the outcome of 
amblyopia treatment in this study was treatment adherence.  
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Amblyopia is defined as a reduction in best-corrected visual acuity, typically 
monocular, in an otherwise normal eye resulting from abnormal visual experience during 
visual development. These abnormal visual experiences usually involve visual 
deprivation or abnormal binocular interaction. Often, the reduction in visual acuity 
cannot be entirely attributed to a structural abnormality of the eye. 1 Amblyopia is 
clinically defined as two-line difference in best-corrected acuity between eyes. 
Amblyopic eyes may also have deficits in contrast sensitivity and accommodation. 2 It 
remains to be the most common cause of monocular visual impairment in children with 
prevalence estimated at 1-5%. 3-7  In North American studies, the prevalence of 
amblyopia has been estimated with higher prevalence rates in the medically underserved 
populations; this is attributed largely to the high default rates from visual screening 
programs. 8,9 In contrast, the prevalence studies of amblyopia conducted in developing 
countries such as India, Nigeria and Ethiopia, report relatively lower rates 10-12. Despite 
amblyopia being a preventable and treatable condition in childhood, the sustained vision 
loss contributes significantly to vision loss in adults. 5  
 
The most important causes of amblyopia can be broadly divided into two 
categories: a) visual deprivation and b) conditions that interfere with formation of vision 
during visual development. 13 Visual deprivation in childhood can be caused by blocking 
of the visual axis from light by a lenticular opacity (cataract), corneal opacity (congenital 






as ocular misalignment (strabismus), a significant difference in the refractive error 
between each eye (anisometropia), and high refractive error causing the light not to focus 
due to the optics of the eye (myopia, hyperopia or astigmatism)--each of these contributes 
to a disruption in vision, as amblyopia can develop with the lack of stimulation of the 
retina. 6 The majority of children with amblyopia have strabismus and/or anisometropia; 
each making up about a third of the cause and a combination of the two making up 
another third. On average, 40-60% of children with anisometropia and/or strabismus in 
childhood develop amblyopia. 14 The severity of disease has been shown to be associated 
with the strabismic cause of amblyopia, resulting in more severe manifestation than 
refractive discrepancy. 5 
 
Amblyopia is primarily a neural disorder resulting from abnormal stimulation of 
the visual cortex during visual development, primarily during the first decade of life. The 
neurophysiologic mechanism for the development of amblyopia has not been fully 
elucidated. 15 Studies have not shown significant physiologic or anatomic abnormalities 
at the level of the retina, even with advances with OCT (optical coherence tomography). 7 
However, animal studies have revealed that neurons in the primary visual cortex and 
lateral geniculate body show significant dysfunction when exposed to abnormal visual 
input during a critical period of visual development. 16 The concept of a critical or a 
sensitive period was based upon the feline studies conducted by Wiesel and Huble. These 
researchers showed that ocular dominance is established in the primary visual cortex cells 
of cats that underwent monocular deprivation between eye opening and several months of 






established, it is an important concept in understanding the development of amblyopia. 
This critical period depends upon the type of visual function, predominantly spatial 
resolution, being studied, and the anatomical level and the visual history of the subject, 
including the severity of the visual deprivation. 17  
 
Subsequent studies have also demonstrated the loss of particular cell types in the 
dorsal lateral geniculate nucleus of visually deprived cats without any observed 
functional deficits of neuronal signaling. 18 Therefore, there are both functional and 
anatomic alterations at the various anatomic levels of visual processing that appear to 
contribute to ocular dominance. Given that information from each eye is initially 
combined in the primary visual cortex, most studies support the idea that abnormal 
receptive field properties of V1 neurons linked to the amblyopic eye contribute most 
significantly to amblyopia. 15 Thus, any neuronal activity responsible for a deficit in 
spatial resolution and a reduction in binocularly driven neurons of the primary cortex 
seem to be the important pathophysiologic links to the development of amblyopia. In 
particular, the most profound anatomic and functional alteration in the visual system has 
been demonstrated in animals with early visual deprivation as compared to those with 
anisometropic or strabismic amblyopia. 15  
 
Similar to the feline studies, surgically induced strabismus in macaques has 
demonstrated amblyopia, with ocular dominance noted in the non-deviating (non-
strabismic) eye as well as the loss of cortical binocularity. 19 Other macaque studies 






drops) or a unilateral -10 diopter lens, both of these studies have demonstrated amblyopia 
and reduced binocularity. 14  
 
  Given the time sensitive nature of amblyopia development and treatment, early 
detection is important. Delayed treatment can result in significant visual impairment. 20 
The American Association of Pediatric Ophthalmology and Strabismus (AAPOS) has set 
recommendations regarding the age appropriate screening of children starting at infancy. 
In the first 6 months of life, assessment of fixation and tracking of objects can be used for 
vision screening. If there are any deficits regarding ocular movement or if there is an 
abnormal red reflex, a complete eye evaluation is recommended. Children over the age of 
6 months can also be assessed for refractive error and/or strabismus by a pediatrician or a 
primary care physician with the use of an automated screening device such as a photo-
screener.  Over the age of 3 or 4 years, vision screening can be done using HOTV letters 
or Snellen eye chart. The tumbling E charts or the Allen or LEA figures can be used in 
cooperative, pre-literate child. 21 
  The utility of screening all preschool children has been a controversial issue. 20 
Photo-screening devices have been developed in an attempt to provide a cost-effective 
screening tool targeted at identifying amblyopia with good specificity at a time where 
treatment can be most effective.  However, current devices have lower than desirable 
specificity to be cost effective for mass screening of preschool children. 6 Additionally, 
lack of randomized clinical trials to analyze the impact of screening programs upon the 






ophthalmologists on the issue of screening. 20 
  However, what is agreed upon is that evaluation for amblyopia should include a 
complete ophthalmic exam with attention for strabismus, refractive error, lenticular 
opacity, and/or retinal disease as well as soliciting a family history for pediatric eye 
disease. 22  The diagnosis of amblyopia is achieved by detection of a two-line difference 
in visual acuity between the two eyes, given that best corrected vision is achieved using 
spectacles (correcting the refractive error). For children able to perform a quantitative 
visual acuity test using the eye chart, the test should ideally use either crowded or line 
optotypes. Amblyopic eyes display the crowding phenomenon, where HOTV letter or 
Snellen letter visual acuities worsen when presented with a row of images on the eye 
chart as opposed to an isolated individual letter. Fixation preference testing is the test of 
choice for those unable to perform a quantitative visual acuity test. In strabismic children, 
the fixating eye is determined.  In children without strabismus, the induced tropia test is 
performed: strabismus is induced using a 10-12-prism diopter vertical prism to assess for 
fixation preference. 1 Bilateral amblyopia should be suspected in cases where best 
corrected visual acuity in either eye measures worse than 20/50 in children 3 years of age 
or younger, or worse than 20/40 in children older than 4 years. 22 
  Amblyopia is a relatively well-understood disease with an established treatment 
modality.  Recent studies conducted by the Pediatric Eye Disease Investigator Group 
(PEDIG) have aimed to provide randomized clinical trials over the last 17 years for 
evidence upon which to base treatment decisions.  The PEDIG is funded by the National 






Amblyopia Treatment Studies (ATS). 22   Treatment for amblyopia has three important 
components: a) providing a clear retinal image for the amblyopic eye, if deprivation 
exists, b) correction of significant refractive errors, and c) forced use of the amblyopic 
eye by occluding or penalizing the fellow eye. 22 
  The role of accurate refraction in children is of great importance both in the 
diagnosis and treatment of amblyopia. The refractive error requires a measurement 
obtained with adequate cycloplegia (the pupil dilated at its maximum). The role of 
glasses alone in treating amblyopia was one of the study questions explored by PEDIG. 
Eighty-four patients between ages of 3 and 7 participated in a study lasting 30 weeks. 
Results demonstrated that 77% of amblyopic eyes improved by 2 or more lines of vision 
by using optical correction alone. Of these patients, 27% showed complete resolution of 
amblyopia with spectacle correction alone. 23 This emphasizes the need for accurate 
refraction and the improvement of vision using spectacles alone. 
  Occlusion, although introduced for children over 250 years ago, remains to be the 
mainstay of treatment for amblyopia. 24 The role of occlusion in the management of 
amblyopia was established by numerous prospective and retrospective studies. PEDIG 
conducted the first such randomized clinical trial comparing occlusion after a stable 
improvement with glasses alone compared to patients treated with only glasses.  A total 
of 180 patients between ages of 3 and 7 were followed for 5 weeks. Patients in the glasses 
plus occlusion group were treated with 2 hours of patching per day combined with 1 hour 
of near visual tasks. Vision improved by 1.1 lines in the treatment group compared with 






occlusion therapy in amblyopia management, including children with refractive 
amblyopia. 
In the early 1970s, total and continuous occlusion during all waking hours was 
thought to be valuable in treating amblyopia.  Since then, there have been wide ranges of 
occlusion treatment regimens. 24 PEDIG trials were conducted addressing this question of 
dosage for occlusion therapy necessary for an optimal visual outcome. The studies found 
that there was no significant difference in outcome between patients with moderate 
amblyopia patched for 6 hours per day versus patients patched for 2 hours per day. 26 
Similarly, in patients with severe amblyopia, there was no significant difference in 
treatment outcome between the full time occlusion group and the part-time occlusion 
group. These studies demonstrated that for initial treatment of amblyopia due to 
strabismus, anisometropia or combined mechanism, starting with a lower dosage of 
occlusion does not decrease the chance of success for improving vision. 26,27   It is 
possible that there might be a treatment adherence benefit to decreasing occlusion time 
without compromising treatment outcome. 
Compliance with patching treatment has been shown to be a significant 
contributor of successful treatment. Lack of compliance leads to further deterioration of 
visual acuity in the amblyopic eye. 28 The need for an objective measure of compliance to 
assess the dose-dependent nature of occlusion therapy led to the development of 
Occlusion Dose Monitors (ODM).  Patients were given an ODM, which consisted of a 
patch modified with electrocardiogram, battery and data logger to objectively monitor 






and clinically informative especially in cases where non-compliance had to be ruled out 
as a possible explanation for poor outcome.  The ability to monitor compliance allows for 
the precise titration of occlusion to prevent loss of visual function. 29 
Other researchers also used ODM measurement to help establish a relationship 
between visual acuity improvement and compliance in children being treated with 
patching. Here, the results showed that there is a significant relationship between 
increased visual acuity and measured compliance. 30 There have been similar studies 
establishing compliance as one of the most important factors affecting outcome of 
amblyopia treatment. 31,32 At the same time, non-compliance rates to occlusion have been 
shown to be as high as 50%. 24 
Given how critical occlusion compliance is to the outcome of visual acuity, 
several studies have been completed to address the factors associated with better 
compliance. A retrospective study by Nucci and colleagues reviewed the charts of 496 
amblyopic subjects to identify factors associated with lower compliance using patient 
report and records of missed appointments to measure non-compliance. The study found 
that lower initial visual acuity, age (less than 2 years old), and poor parental 
understanding to be significantly correlated with less complaint patients. 33 On the other 
hand, another retrospective study conducted in Australia evaluated the patching 
compliance in 127 children for amblyopia management. 34 In this study, there was no 
difference in compliance among the genders, across diagnostic class or treatment 
duration, with younger and older children showing better compliance compared with 
children at 15-30 months reporting significantly worse compliance. 34 There are some 






compliance. However, despite the variation in results regarding which factors truly 
influence compliance, studies have demonstrated that non-adherent parents have 
significantly poor understanding of the amblyopic critical period and confusion regarding 
which eye needed to be patched. 35 
Atropine penalization is an alternative approach to patching occlusion for 
amblyopia therapy. This eye drop treatment prevents the treated eye from 
accommodating, resulting in blurred vision at near; thereby allowing the amblyopic eye 
to be used preferentially. Its use is usually advocated when the amblyopic eye has vision 
better than 20/100, since this level of visual acuity might not give the amblyopic eye a 
preferential advantage over the atropinized, better seeing eye.36 The first PEDIG study 
evaluated at the efficacy of Atropine 1% (1 eye drop daily) as compared to patching for 6 
hours daily in 419 patients between the ages of 3 and 7 with moderate amblyopia. 36 At 6 
months, 75% of both groups achieved approximately 3 lines improvement in vision with 
a faster improvement rate seen in the patching group.36 At the 2 year follow- up, visual 
acuity outcome in both patient groups were similar, suggesting that both treatments are 
equally efficacious. 36,37  
Subsequent PEDIG investigations point to a potential benefit of using atropine 
penalization over patching when it comes to improving rates of treatment compliance.  At 
the same time, another PEDIG study assessed the quality of life and psychosocial impact 
of amblyopia treatment on the child and family using a standardized questionnaire called 
Amblyopia Treatment Index (ATI). 38 Parents completed the questionnaire at 5 weeks 
into the treatment period.  Results from the ATI showed that both treatment groups, 






children in the patching group performed worse than the children in the atropine group on 
all three subscales of the questionnaire including compliance, social stigma and/or 
adverse effects.38  
There are limited studies performed in the East African region looking at the 
outcomes of pediatric eye disease. Even less research has been performed to address the 
epidemiology, characterization, management and compliance of amblyopic children in 
the region.  In 2008, a study addressing amblyopia in Ethiopian children examined the 
clinical profile of patients presenting to the Ethiopia’s main pediatric ophthalmology 
referral center.39  This study, Profile of Amblyopia at the Pediatric Ophthalmology Clinic 
of Menelik II Hospital, Addis Ababa, evaluated at the magnitude and clinical profile of 
amblyopia among children presenting to the pediatric ophthalmology clinic of Menelik II 
Referral Hospital. Data collected over a five month period included visual acuity, 
refractive status and fixation pattern of all patients presenting to the clinic. From the 
1,660 children examined, 183 (9.1%) were amblyopic with approximately equal divide 
between the genders. The mean age of presentation was 6.9 years with strabismic 
amblyopia being the most common subtype seen at 39.3%. Regionally, 72.1% of children 
lived in the capital, Addis Ababa while the other children, 27.9%, came from other parts 
of Ethiopia.39  The average age of initial presentation for amblyopia was 6.2 years for 
combined mechanism amblyopia, 6.8 years for strabismic amblyopia and 7.4 years for 
anisometropic amblyopia. The problem of amblyopia was detected during evaluation for 
strabismus in 69.4% of the children.39 In this hospital-based study, the delay to initial 






Learning from this 2008 Ethiopian amblyopia study, we conducted our clinical 
research to better understand the barriers to optimal management of amblyopia in 
children presenting to the ophthalmology department at Menelik II Referral Hospital, 
Addis Ababa, Ethiopia.  Our study aims to identify factors which are associated with 
higher compliance in the treatment of amblyopia and thus improved visual acuity 
outcomes.  As strabismic and anisometropic amblyopia are the most frequent causes of 
amblyopia in children, our study focuses upon the treatment of strabismus and refractive 
error as the main etiologies of amblyopia. In addition, we plan to identify factors that lead 
to improved compliance with amblyopia treatment and this will allow physicians to 

































We hypothesize certain determining factors which are associated with better 
compliance in the treatment of amblyopia in children presenting to the ophthalmology 
department at Menelik II Referral Hospital, Addis Ababa, Ethiopia will: (1) help pediatric 
ophthalmologists to better anticipate barriers to treatment of amblyopia and (2) improve 
visual acuity outcomes. We anticipate that parents’ educational level, their understanding 
of the rationale for treatment recommended, and the duration of treatment will play a 




1. To determine the rate of non-adherence to amblyopia treatment in this patient 
population 
2. To determine the demographic and clinical factors that are associated with higher 
rates of non-adherence to amblyopia treatment   
Secondary Aims: 
1. To determine the visual outcome from patching occlusion treatment in this patient 
population 








Recruitment, Inclusion and Exclusion Criteria 
 
Our study was a hospital-based cross-sectional, observational study at the 
pediatric ophthalmology clinic of Menelik II Referral Hospital in Addis Ababa from 
March 2015 to June 2015. Institutional review board (IRB) approval was obtained. It was 
designed to include children between ages 4 to 8 years old.  This age range was chosen 
because these children could provide a more reliable and consistent visual acuity. 
Additionally, at the time of recruitment, we believed there would be a sufficient number 
of children at the clinic within this age group meeting inclusion criteria for our study. 
Our study examined patients with a clinical diagnosis of strabismic, 
anisometropic or a combined mechanism of amblyopia undergoing patching treatment. 
These three causes of amblyopia were selected because they constitute the majority 
etiology of amblyopia and share similar diagnostic, therapeutic, and prognostic features 
as compared to sensory deprivation amblyopia. Strabismic amblyopia was defined as an 
ocular misalignment and associated with an interocular visual acuity difference of at least 
0.2 logMAR units in verbal and cooperative children. Anisometropic amblyopia was 
defined as a refractive difference of greater or equal to one diopter in any meridian. 
Patients were excluded if they had neurologic, traumatic or other structural ocular 
disease, or previous ocular surgery. In addition, patients with sensory deprivation 








Study Procedure  
 
The clinical charts of patients were screened daily throughout the study period to 
determine eligibility. Verbal consent was requested and obtained from parents for 
participation in our study. As previously noted, we obtained permission to review 
patient’s medical records.  
 
 Demographic information, medical and surgical history, family history 
pertinent to eye disease, and social history were collected on the initial patient encounter. 
Results from the eye exam which characterized the presence and severity of amblyopia as 
well as measures of refractive error, ocular motility and ocular alignment were collected 
from enrolled patients.  
 
 Typically, an initial assessment of patients presenting to this clinic with the risk 
factors for amblyopia were evaluated with a detailed history related to the age of onset as 
noticed by the parent or guardian, age at presentation to the hospital, and any previous 
treatments for amblyopia. The uncorrected and best-corrected visual acuity were 
measured for children over the age of 4 years. For children presenting at less than age 4 
years, fixation preference using corneal light reflex was recorded. A completed eye exam 
was performed including the assessment of ocular alignment and ocular motility.  Slit 
lamp examination and fundus examination for the assessment of anterior segment and 






error was performed from cycloplegic refraction and retinoscopy.  
 
Initial and Final Visual Acuity  
Visual acuity was obtained using the 5-letter tumbling E visual acuity chart. 
Visual acuity was recorded as the smallest complete line of five letters read, plus the 
number of letters correctly identified in the line below while wearing proper spectacle 
correction. We only recorded visual acuities obtained before start of treatment (from 
chart review) and at the final counter with the treating clinician.  
 
Treatment protocol  
The selection of a treatment regimen, such as the number of hours needed for 
occlusion therapy, was based upon the treating physicians’ preferences.  In particular, the 
time necessary for occlusive patching was primarily based on the patient’s degree of 
amblyopia, although individual patient flexibility was applied in order to promote 
compliance. Full time occlusion was avoided in our study in order to avoid disruption 
from schoolwork. Part time occlusion consisted of an average of 4 hours of occlusion 
patching per day after school during weekdays and 10-12 hours per day during the 
weekend. A nurse gave parents instructions on how to make a one- time patch using an 










Patient follow- up 
The length of time between follow-up visits for an amblyopic patient undergoing 
occlusion therapy at Menelik II Referral Hospital was determined by the treating 
physician, using the patient’s age as a guideline. A maximum patching interval of 1 week 
was implemented for every year of the patient’s age, with the initial interval not longer 
than 4 weeks, regardless of age. 
 
Administered questionnaire  
Data on each enrolled patient was collected from the parents using a semi-
structured interview consisting of a) Basic parental information, b) Amblyopia Treatment 
Index survey, and c) Parental awareness of amblyopia and knowledge of occlusion 
therapy, critical period, visual prognosis and treatment regimen.  
The basic parental information portion of the questionnaire addressed the 
following: whether the respondent was responsible for the child’s treatment 
administration the majority of the time, what prompted the parent to first seek an 
ophthalmologic consultation, the family’s city of residence, preferred language, and 
educational level.  
The Amblyopia Treatment Index (ATI) was developed by the PEDIG group for 
assessing the impact of amblyopia treatment on 3- to 6-year old children and their 
parents. 40  The items on this questionnaire have three subscales intended to 






20 Likert-type items with 6 response choices ranging from “strongly agree” to “strongly 
disagree.” The ATI was slightly modified for our study purposes to 4 response choices 
which included “0 = all of the time,” “1 = most of the time,” “2 = some of the time,” and 
“3= none of the time” so as to make the questionnaire more accessible to the parents of 
our patient population. This was based upon consultation with treating physicians at the 
pediatric ophthalmology clinic at Menelik II Referral Hospital. Of note, the modified 
questionnaire was translated by a professional language translator into Amharic, the 
national language of Ethiopia. 
 
Scores for the three subscales of the ATI were calculated from the sum of each 
response item within the subscale. Compliance was calculated out of a total of 12 points 
with higher points indicating better compliance. Similarly, social stigma and adverse 
effects of occlusion therapy were calculated out of a total of 9 and 18 points, respectively, 
with higher scores indicating lower stigma and minimal adverse effect with treatment. 
 
The third component of our questionnaire consisted of questions clarifying 
parental awareness of amblyopia, knowledge of occlusion therapy, critical period, visual 
prognosis and treatment regimen. Parents were asked if their child had decreased vision 
in one eye and what treatment the child was receiving for the ocular condition. They were 
asked basic questions addressing the appropriate time for amblyopia treatment, the 
current regimen of treatment and what they found to be most challenging about treating 






administer patching in the previous week.  Non-adherence was then calculated as a ratio 
of the difference between prescribed and administered hours to prescribed hours.  
 
i. e.  Non-adherence = Prescribed hours – Administered hours 
                                 Prescribed hours          
All research activities, including protocol development, recruitment, screening, 


















The association between non-adherence and gender, age at initial presentation, 
parental education, parental awareness of amblyopia, social stigma, and adverse effects of 
amblyopia treatment was studied.  Preliminary analysis by single variable regression was 
applied and then further by multivariate regression analysis. All estimation will be 
adjusted for other variables, along with crude estimation reported.  Further exploratory 
analysis was conducted for factors associated with treatment outcome, evaluated by 
residual amblyopia. Due to our study’s small sample size, calculations with a p-value 











Parents of fifty-nine patients with amblyopia undergoing occlusion (patching) 
therapy were approached for screening to determine eligibility. All parents agreed to 
participate. Six of these patients were under the age of four, and thus were excluded. Of 
the remaining fifty-three patients, seven patients had incomplete charting of initial visual 
acuity and were excluded from the visual outcome analysis, but were included for non-
adherence analysis. All study participants spoke sufficient Amharic and language 
translators were not required to conduct our semi-structured interviews.   
 
Study participants characteristics 
 
The mean age of study participants was 6.4 + 1.3 years (range = 4 to 8 years). The 
mean age at the start of treatment was 3.7 + 1.6 years (range = 0.4 to 7 years). 
Demographics included that 45% (n=21) of participants were male and 54% (n=25) were 
female.  Strabismic amblyopia was identified in 68% (n=36) of the patients, 
anisometropic amblyopia was identified in 11.3% (n=6) of the patients, and a combined 
mechanism was identified in 20.7% (n=11) of the patients. A majority of the patients, 
reported at 77.3% (n=41) as residents of the capital city, Addis Ababa; in contrast, 22.6% 
(n=12) of the patients travelled variable distances, frequently over 50 miles, from regions 






More than half of our patients’ parents interviewed, at 62.3% (n=33), were the 
primary care taker of the child and administered the patching treatment the majority of 
the time. Of these parents, 35.8% (n= 19) administered treatment about half of the time, 
sharing the responsibility with others in the house hold. Of note, one parent administered 
the patching treatment rarely. The task of administering occlusion treatment was 
performed mainly by parents: either mothers (52.8%) or the fathers (33.9%). To a lesser 
extent, older siblings and other extended family members were involved in administering 
the occlusion therapy. A summary of the distribution of demographic and clinical 
















































































































































































































Dose of occlusion 
(hours/day) 




















       47.2% (25) 
       50.9% (27) 
     1.89% (1) 
Parental education 
level 
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     17.0% (9) 
        2.77% (2) 
Residence 
Addis Ababa 
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   73.6% (39) 




Notably, distribution of patients with regards to severity of amblyopia measured 
by their initial visual acuity showed that 45.3 % (n=24) of patients fall into the moderate 
amblyopia group with LogMaR visual acuity measures between 0.4 to 0.7. At initial 
presentation, the largest age group of patients was between the ages of 2 and 4 years 
(37.7%) (n=20) with 68% of all patients presenting with an ocular misalignment.  The 
classification of ocular misalignment among patients treated for strabismus and combined 
mechanism amblyopia (n=47) is described for 42 of these patients in Table 2. 
 
 
Table 2. Classification of ocular misalignment for children with strabismic amblyopia 
Type of strabismus  Frequency Percent 
 Infantile Esotropia 2 4.76 
  Accommodative esotropia 35 83.3 
  Acquired non-accommodative esotropia 1 2.38 
  Infantile Exotropia 4 9.52 
  Total 42 100 
 
 
Duration of treatment for our patients varied widely: from 1 month of follow-up 
to 68 months of follow-up.  The mean duration of treatment was 19 months with an 






mechanism amblyopia, the most common treatment time was within the 24-48 months 
duration. 
The most common dosage of occlusion reported by parents was in the strabismic 
amblyopia patients, with 28-44 hours per week and ≤ 28 hours per week reported in 17 
patients (32.1%) and 18 patients (34%), respectively. Of note, 25 patients (53.2%) were 
patched up to 44-hours per week (4 hours during the week day and 10-12 hours during 
the weekends), especially the patients with strabismic amblyopia. The second largest 
dosage group was 14-hours per week (2 hours daily) with 31.9% of patients (n=15) in 
this group. 
In addition to occlusion therapy, refractive correction with glasses was part of the 
amblyopia management for 88.6% of patients (n=47) in the study. Of these patients 
wearing spectacles, 67.9% (n=36) patients were adherent with their current prescriptions 
at the time of our encounter, while 20.7% (n=11) patient were not adherent. 
 
Educational level of parents had a wide range of distribution: no formal 
education, only primary education (1st to 8th grade), up to high school (12th grade), 
college, and graduate level. The largest group of parental education level was noted as 











Summary of questionnaire results  
 
Results from our modified ATI questionnaire were divided into the compliance, 
adverse effects, and social stigma subscales. Numerical results from each subscale were 
the sum of individual questions within each subscale. The mean value for the compliance 
subscale (calculated out of a total of 12 points with higher score representing better 
compliance) for all study participants was 8.57 + 3.51. The mean value for social stigma 
subscale (calculated out of a total of 9 points with higher score representing lower social 
stigma of treatment) was 7.26+ 2.28. The mean value for the adverse effects subscale 
(calculated out of a total of 18 points with higher values representing least treatment 
associated adverse effects) was 16.08+ 2.30. A graphical representation for the 











Figure 1. Distribution of ATI subscale scores in participants. A. Compliance; B. 









Table 3 is a summary of the responses obtained from parents regarding their basic 
knowledge of amblyopia and its treatment. The results showed that parental 
understanding was generally poor in important areas such as critical period, as shown by 
responses to questions addressing age limit to treatment and the preferred age of 
administering treatment. We noted that 13% (n=7) of parents were found to be patching 
the incorrect eye. This subset of patients had a median duration of follow-up of 16 
months. Given this length of treatment duration, this error in implementing amblyopia 
treatment is particularly striking.  
 
Table 3: Parental awareness of amblyopia and knowledge of occlusion, critical period, 
visual prognosis and treatment regimen 
 
Questions Number (%) of parents giving the correct 
answer (N=53) 
Does your child have reduced vision in one 
eye? 
42 (79) 
What is the treatment for reduced vision in 
one eye? 
37 (70) 
Does the treatment have to be carried out 
by a certain age? 
23 (43) 
Would it be easier to correct weak vision in 
one eye at age 2 years or 6 years? 
24 (45) 














All 53 enrolled parents completed our questionnaire and provided an estimate of 
the number of hours of prescribed amblyopia treatment they were able to administer the 
week prior to their follow-up appointment.  Non-Adherence was then calculated as a ratio 
of missed hours (difference between prescribed and administered hours) to prescribed 
hours. The distribution of calculated non-adherence score for our cohort is graphically 
presented in Figure 2.  The median non-adherence score was 0.41 with 25% and 75% 
percentiles of 0.21 and 0.625. Patients with greater than 0.5 calculated non-adherence 
were considered to have poor adherence to treatment. This group constituted 28% of our 
study participants.  
 
 









Regression Analyses for non-adherence 
 
The association between calculated non-adherence scores and the various 
demographic and clinical factors including: age at the start of treatment, gender, type and 
severity of amblyopia at the start of treatment (categorized as mild: <0.4 logMAR in the 
amblyopic eye; moderate: >0.4 to <0.7 logMAR; or severe: >0.7 logMAR), prescribed 
hours for occlusion therapy, duration of treatment for occlusion, number of clinic visits, 
compliance with glasses, parental educational level, place of residence, primary language 
spoken, questionnaire results addressing compliance, adverse effects of occlusion 
therapy, social stigma of occlusion therapy, parental knowledge of amblyopia and its 
treatment, and residual amblyopia were statistically interrogated by single variable and 
multivariate regression analysis. The resulting final model is summarized in Table 4. 
Validity of underlining model assumptions were assessed graphically and analytically. 
 
Parental education level (p= 0.003) and residual amblyopia (p=0.001) were found 
to be significantly associated with non-adherence.  Compared to parents with a college 
level education or higher, parents with a high school education or less were more likely to 
be non- adherent to patching. With regards to residual amblyopia, those children with 
smaller level of residual amblyopia, i.e better treatment outcome, were found to be more 







  Although statistical significance was not reached, initial visual acuity (severity of 
disease) and adverse effects of treatment were also marginally associated with non-
adherence.  Patients with worse initial visual acuity or more severe disease had worse 
adherence to therapy. Patients with lower adverse effect subscale scores (suffered greater 
adverse effect from treatment) also demonstrated worse adherence to patching. All other 
variables were not significantly associated with the calculated non-adherence scores. 
 
 
Table 4: Summary of Multivariate Analysis for Calculated Non-Adherence Scores 
 
Variables Unadjusted Coefficient  Adjusted Coefficient 
Estimate SD p-value Estimate SD p-value 
Parental educational level 
  College and above 



















Adverse Events 0.027 0.014 0.064 - - - 
Initial Vision Acuity 0.173 0.095 0.075 - - - 
Residual amblyopia  0.317 0.093 0.001 0.293 0.0855 0.001 
 
Reasons for parental non-adherence  
 
All 53 parents were asked to provide their family’s primary reason for non-
adherence and 88.7% (n=47) were able to provide at least one reason. The most common 
reason for non-adherence given by 37.7% (n=20) of all parents was lack of cooperation 
from the child. Parents indicated that the child disliked the patch and often resisted or 
tried to avoid being patched. Competing priorities and other life stressors, including busy 
work and home life, was the next most sited reason (30.2%) for non-adherence to 






treatment (n=5) constituted the primary reason for non-adherence to occlusion therapy for 
the remaining parents.  
 
Visual outcome of treatment  
 
Given our small cohort of patients (N=53), especially within the anisometropic 
and combined mechanism amblyopia groups, it is difficult to make associations between 
visual outcome and our clinical or demographic variables by diagnostic grouping. 
Therefore, children within the three diagnostic types of amblyopia (strabismic, 
anisometropic and combined mechanism) were considered together. The initial and final 
visual acuity was recorded by the tumbling E-chart in 46 (86.8%) of the children. Of 
these patients, 4.35% achieved 6/9 or better, 23.9% 6/18 or better and 71.7% achieved 
less than 6/18. Visual outcome for each group is shown graphically in Figure 3. 







Figure 3: Summary of final visual acuity for each diagnostic type of amblyopia. 
 
Neither age at the start of treatment (Figure 4) nor duration of treatment (Figure 5) 
were associated with final visual outcome (p=0.158 and p=0.151, respectively). 
Similarly, severity of disease as measured by the initial visual acuity of the patients was 
not found to be associated with visual outcome (p≥0.1). 
 
In contrast, the final visual acuity in our cohort of patients was found to be 
significantly associated with calculated non-adherence score (p = 0.00132) and the 
compliance subscale of the ATI questionnaire (p=0.00137). Patients who were more 






compared to those who were less adherent. All other variables were not significantly 
associated with the final visual acuity. 
 
 




















Our study has explored the effects of various demographic and clinical parameters 
upon adherence to amblyopia treatment at the pediatric ophthalmologic referral hospital 
in Addis Ababa, Ethiopia. Approximately one-third of the parents (28%) were found to 
be non-adherent to the amblyopia treatment. Our reported level of non-adherence is 
significantly lower than levels determined by Newsham et al (54%) because non-
adherence in their study was determined using an 80% threshold to divide non-adherence 
from adherence as compared to a threshold of 50% for our study.35  If an 80% threshold 
were to be used, the percentage of non-adherent parents in our study would be calculated 
at 58.5%. This is a higher level of non-adherence than cited by most studies.41,42 The 
variation in adherence rates across the literature can be partly explained by the variation 
in methodology adopted.  
 
Most studies, like the Newsham study, determine adherence to amblyopia 
treatment and factors influencing adherence to treatment with the use of a diary, in 
addition to the use of an occlusion dose monitor, which is attached to the occluding 
material.36 This is a major drawback for our study since we had to rely solely on parental 
recall and self-report of treatment administration the week prior to our clinical encounter.  
Therefore, it is likely that the true percentage of non-adherent parents in our study may be 
higher than calculated. In turn, parents are likely to overestimate their adherence to 






physicians recommendation, and thus reluctant to disclose the full extent of their non- 
adherence. It should be noted that an effort was made to use non-judgmental language in 
obtaining information about non-adherence and in relating to parents that information 
obtained for the study would in no way affect their follow-up care at the clinic. It is also 
important to consider that our study only looked at non-adherence as a snap shot, during a 
period of one week, with participating parents at different lengths of treatment duration. 
It is very likely and expected that the level of parental adherence to treatment may vary 
during treatment period, especially given the limitation of evaluation of our four-month 
period. 
 
In our study, we identified parental level of education and residual amblyopia as 
statistically significant predictors for non-adherence.  Adverse effects of treatment and 
initial visual acuity were also found to be marginally associated with non-adherence. Age 
of onset of therapy, gender, type of amblyopia, duration of treatment, use of spectacles, 
parental awareness of amblyopia, and social stigma as measured by the ATI 
questionnaire did not appear to be significant predicators of non-adherence. Given our 
small sample size, further sub-group analysis is not warranted and a larger cohort of 
patients may yield different results. 
 
Parental level of education was found to be a significant predictor of adherence in 
a study conducted in the Netherlands by Loudon et al. In this study, the 310 participating 






background-- enabling the investigators to asses the role of these demographic factors on 
adherence.  
The study also found parental fluency in Dutch and parental country of origin to 
be associated with adherence. 43 Although a smaller cohort, our study participants’ 
educational level ranged from no formal education to graduate level education. Parents 
with only high school level education or less demonstrated poorer adherence than those 
with exposure to college education and beyond.  Thus, parents with limited education 
require greater attention with regards to explanation of the treatment regimen in 
appropriate terminology for improved understanding of the importance of amblyopia 
treatment practices. 
 
As in our study, the benefit of improved visual acuity (as measured by reduced 
residual amblyopia) in significantly influencing adherence has been previously 
demonstrated. Studies have demonstrated the importance of “self-efficacy “as a factor in 
determining parental adherence to patching treatment. In a research conducted by Searle 
et al, parents who believed treatment to be bringing about change in the functional vision 
of their child were more likely to adhere to treatment. This led to the finding that there is 
a benefit to emphasize the evidence of visual acuity improvement of children to their 
parents during follow up visits in order to encourage adherence. 44  Similarly, a 
qualitative study in Great Britain by Dixon-Woods et al used interviews with families of 
children with amblyopia to better characterize the challenges associated with occlusion 
therapy.44   These researchers found that parents were more likely to abandon treatment 






educationally.45  These findings can plausibly be expected as parents who are more aware 
of the improvements being gained from therapy would proceed to treat better than those 
parents who are not seeing or understanding the benefits of occlusion therapy. The 
importance of addressing the improvement in vision as amblyopia treatment progresses 
could make a significant difference in motivating parents to continue adhering to the 
treatment regiment prescribed.  
 
Initial visual acuity has been shown to be an important predictor of treatment 
adherence in a study of 496 amblyopic patients conducted by Nucci et al. 33  A more 
recent study has also demonstrated that initial visual acuity is the only clinical factor most 
significantly associated with adherence.43 This has been attributed to the fact that children 
with worse initial visual acuity in the affected eye resist patching more than those with 
better initial acuity. Thus, parents would find themselves having to do more work to 
convince and apply occlusion treatment regularly.  Understandably, adherence also 
suffers further if parents perceive amblyopia treatment as having a deleterious effect on 
their child’s ability to perform educationally or socially.45 
 
In our cohort, parents have demonstrated a very poor understanding of amblyopia, 
its treatment and visual prognosis. For this reason, we had anticipated that parental 
awareness as assessed through our questionnaire would significantly be associated with 
adherence to amblyopia treatment. Although parental comprehension did not emerge as a 
significant predictor of treatment adherence in our cohort analysis, other studies have 






research in other areas of medicine have certainly demonstrated that the understanding 
level of patients with regards to their condition or diagnosis can have a direct and 
profound effect on their adherence to therapy.  
 
Parental knowledge of both the critical period in amblyopia and the preferred age 
at which occlusion treatment should be started were quite poor in our study.  
Approximately 56.6 % of parents were unsure about the most favorable time to 
administer treatment and only 20% of parents scored 5 out of 5 with regards to their basic 
knowledge of amblyopia while 13% of the parents were patching the incorrect eye. This 
lack of knowledge suggests that parents do not fully appreciate the urgency of treatment, 
which can lead to further non-adherence.  A better understanding of amblyopia, the 
importance of treating early, and the goals of amblyopia treatment can reinforce the 
urgency and efficacy of the treatment to parents. In our study, 26.4 % of parents did not 
have a clear understanding of what patching was intending to treat.  Some parents 
communicated the expectation that the surgery planned at the end of the patching therapy 
to be the most important aspect of the management, and in turn, making patching less of 
priority. Other parents related their understanding that patching was intended to treat the 
ocular misalignment rather than the decreased vision. 
 
Our study also exposed a significant deficiency in parental understanding of the 
role of glasses in treating amblyopia. Out of a subset of 18 parents who were specifically 
asked if they applied the glasses on their child after patching, the majority of parents, that 






patched. This exposes a gap in the information related to parents regarding the role that 
glasses play in the management of amblyopia.  
 
An RCT study by Newsham et al looked at the role of intervention in the form of 
education material provided to parents to improve their understanding of amblyopia and 
patching and thereby increase adherence. Patients were randomized to a leaflet group or a 
control group. In the leaflet group, they were issued written educational material whereas 
in the control group, additional educational material was not provided. Patients were 
paired and matched for age and occlusion time prescribed.45 The study found the level of 
knowledge in key areas of amblyopia and adherence to occlusion therapy to be 
significantly greater in the leaflet group; moreover, only parents in the control group were 
patching the incorrect eye.45 This study suggested that providing educational material for 
parents helps clarify the concept of the amblyopia critical period, the importance of 
patching and the consequences of not treating. At the same time, researchers concluded 
that providing educational material to improve parental understanding of amblyopia 
could lead to improved adherence to amblyopia treatment.46 
 
Given low literacy rates in Ethiopia, especially in patients coming from a rural 
setting outside of Addis Ababa with very limited or no exposure to formal education, 
more creative ways should be used to communicate the importance of better adherence 
and timely treatment for preventing amblyopia.  In a Dutch study conducted by Tjiam et 
al, they describe the effectiveness of an educational cartoon shown in a clinical setting, 






This research showed improvement in electronically-measured adherence to patching and 
clinic attendance.46 It also demonstrated an improvement with adherence following the 
implementation of the cartoons being more pronounced in patients of low socioeconomic 
status, with a large portion of these patients being immigrants who spoke Dutch poorly.47 
Similarly, for our study population, educational material prepared in a leaflet format, not 
requiring words, could provide greater awareness of the importance of treating amblyopia 
in their children and improve adherence in both illiterate parents and parents who do not 
understand or speak the national language fluently.  
 
There was a wide range of reasons described by the parents in our study as the 
primary challenge to administer occlusion therapy: unwillingness of the child to tolerate 
the patching, competing socioeconomic priorities associated with poverty, challenging 
family dynamics, lack of resources including the simple materials required for occlusion 
patching. While improving parental understanding is expected to increase compliance, it 
is also important to emphasize that treating physicians address the particular challenges 
families face with regard to implementing treatment. A study by Tripathi et al 
investigated the role of parental preference in planning occlusion treatment and thereby 
improving adherence.47 The study showed that parents had strong preferences for one 
occlusion regimen over another, based upon their particular circumstance and family 
situation.48  It is intuitive that by empowering parents to voice their preferences and 
determine what patching treatment regimen works best for their families, there will be an 
improved adherence to amblyopia treatment. Such discussions would also help find 






appropriate occlusive material, which in our study was noted by parents as one of the 
reasons for non-adherence to treatment. 
  In summary, our 14-week retrospective and prospective cohort study 
demonstrated that non-adherence to patching treatment was associated with worse initial 
visual acuity and lower parental education level. While there was not a significant 
difference between the initial visual acuity and final visual acuity in our cohort of 
patients, this factor represents two facets. One facet is that a 14-week period of time is 
difficult to achieve lasting and transformative results regarding improved visual 
outcomes, especially in amblyopia associated with accommodative esotropia, as this was 
the diagnosis in the majority of our patients with strabismic amblyopia. A second facet is 
that worse initial visual acuity represents a deeper loss of binocular vision and 
compounded with non- adherence to amblyopia treatment, it is difficult to achieve 
improved final visual outcome.   Our study of this cohort of children at the pediatric 
ophthalmology clinic at Menelik II Referral Hospital serves as a springboard to further 
studies to help treating physicians better communication with parents for a better 










1. Repka MX. Amblyopia Management In: Hoyt CS, ed. Pediatric Ophthlalmology 
and Strabismus 4ed: Elsevier Limted; 2013:726-732. 
2. American Academy of Ophthalmology Pediatric Ophthalmology/Strabismus 
Panel. Preferred practice pattern Guidelines. Amblyopia.  San Francisco, CA: 
American Acadamy of OPhthalmology. 2012. Available at 
http://one.aao.org/CE/PracticeGuidelines/PPP.aspx. Accessed September 16, 
2015. 
3. Simons K, Stein L, Sener EC, Vitale S, Guyton DL. Full-time atropine, 
intermittent atropine, and optical penalization and binocular outcome in 
treatment of strabismic amblyopia. Ophthalmology. 1997;104(12):2143-
2155. 
4. Donahue SP, Ruben JB, et al. US Preventive Services Task Force vision 
screening recommendations. Pediatrics. Mar 2011;127(3):569-570. 
5. Holmes JM, Clarke MP. Amblyopia. Lancet. 2006;367(9519):1343-1351. 
6. Wu C, Hunter DG. Amblyopia: diagnostic and therapeutic options. Am J 
Ophthalmol. Jan 2006;141(1):175-184. 
7. Wong AMF. New concepts concerning the neural mechanisms of amblyopia 
and their clinical implications. Canadian Journal of Ophthalmology-Journal 
Canadien D Ophtalmologie. Oct 2012;47(5):399-409. 
8. Williamson TH, Andrews R, Dutton GN, Murray G, Graham N. Assessment of 
an inner city visual screening programme for preschool children. Br J 
Ophthalmol. Dec 1995;79(12):1068-1073. 
9. Friedman DS, Repka MX, Katz J, et al. Prevalence of amblyopia and 
strabismus in white and African American children aged 6 through 71 
months the Baltimore Pediatric Eye Disease Study. Ophthalmology. Nov 
2009;116(11):2128-2134 e2121-2122. 
10. Ganekal S, Jhanji V, Liang YB, Dorairaj S. Prevalence and Etiology of 
Amblyopia in Southern India: Results from Screening of School Children Aged 
5-15 years. Ophthalmic Epidemiology. Aug 2013;20(4):228-231. 
11. Megbelayin EO. Prevalence of amblyopia among secondary school students in 
Calabar, south-south Nigeria. Nigerian journal of medicine : journal of the 
National Association of Resident Doctors of Nigeria. Oct-Dec 2012;21(4):407-
411. 
12. Mehari ZA, Yimer AW. Prevalence of refractive errors among schoolchildren 
in rural central Ethiopia. Clin Exp Optom. Jan 2013;96(1):65-69. 
13. Sjostrand J, Abrahamsson M. Risk factors in amblyopia. Eye (Lond). 1990;4 ( 
Pt 6):787-793. 
14. Kiorpes L, Kiper DC, O'Keefe LP, Cavanaugh JR, Movshon JA. Neuronal 






experimental strabismus and anisometropia. The Journal of neuroscience : the 
official journal of the Society for Neuroscience. Aug 15 1998;18(16):6411-
6424. 
15. Kiorpes L, McKee SP. Neural mechanisms underlying amblyopia. Current 
opinion in neurobiology. Aug 1999;9(4):480-486. 
16. Huble DH WT. The period of susceptibility to the physiological effects of 
unilateral eye closure in kittens. J Physiol. 1970;206(2):419-436. 
17. Daw NW. Critical periods and amblyopia. Arch Ophthalmol. Apr 
1998;116(4):502-505. 
18. Sherman SM, Hoffmann KP, Stone J. Loss of a specific cell type from dorsal 
lateral geniculate nucleus in visually deprived cats. Journal of 
neurophysiology. Jul 1972;35(4):532-541. 
19. Aslin RN, Alberts JR, Petersen MR. Development of perception : 
psychobiological perspectives. New York: Academic Press; 1981. 
20. Powell C, Hatt SR. Vision screening for amblyopia in childhood. The Cochrane 
database of systematic reviews. 2009(3):CD005020. 
21. Patient Info. Vision screening recommendations.  
http://www.aapos.org/terms/conditions/131 
. 
22. DeSantis D. Amblyopia. Pediatric clinics of North America. Jun 
2014;61(3):505-518. 
23. Cotter SA, Pediatric Eye Disease Investigator G, Edwards AR, et al. Treatment 
of anisometropic amblyopia in children with refractive correction. 
Ophthalmology. Jun 2006;113(6):895-903. 
24. Fielder AR, Irwin M, Auld R, Cocker KD, Jones HS, Moseley MJ. Compliance in 
amblyopia therapy: Objective monitoring of occlusion. British Journal of 
Ophthalmology. 1995;79(6):585-589. 
25. Wallace DK, Pediatric Eye Disease Investigator G, Edwards AR, et al. A 
randomized trial to evaluate 2 hours of daily patching for strabismic and 
anisometropic amblyopia in children. Ophthalmology. Jun 2006;113(6):904-
912. 
26. Repka MX, Beck RW, Holmes JM, et al. A randomized trial of patching 
regimens for treatment of moderate amblyopia in children. Archives of 
Ophthalmology. 01 May 2003;121(5):603-611. 
27. Holmes JM, Kraker RT, Beck RW, et al. A randomized trial of prescribed 
patching regimens for treatment of severe amblyopia in children. 
Ophthalmology. Nov 2003;110(11):2075-2087. 
28. Simons K, Preslan M. Natural history of amblyopia untreated owing to lack of 
compliance. Br J Ophthalmol. May 1999;83(5):582-587. 
29. Fielder AR, Irwin M, Auld R, Cocker KD, Jones HS, Moseley MJ. Compliance in 







30. Loudon SE, Polling JR, Simonsz HJ. A preliminary report about the relation 
between visual acuity increase and compliance in patching therapy for 
amblyopia. Strabismus. 2002;10(2):79-82. 
31. Woodruff G, Hiscox F, Thompson JR, Smith LK. Factors affecting the outcome 
of children treated for amblyopia. Eye (Lond). 1994;8 ( Pt 6):627-631. 
32. Oliver M, Neumann R, Chaimovitch Y, Gotesman N, Shimshoni M. Compliance 
and results of treatment for amblyopia in children more than 8 years old. 
American Journal of Ophthalmology. 1986;102(3):340-345. 
33. Nucci P, Alfarano R, Piantanida A, Brancato R. Compliance in antiamblyopia 
occlusion therapy. Acta Ophthalmologica. 1992;70(1):128-131. 
34. Chua BE, Johnson K, Martin F. A retrospective review of the associations 
between amblyopia type, patient age, treatment compliance and referral 
patterns. Clinical & Experimental Ophthalmology. 2004;32(2):175-179. 
35. Newsham D. Parental non-concordance with occlusion therapy. British 
Journal of Ophthalmology. 2000;84(9):957-962. 
36. Pediatric Eye Disease Investigator G. A randomized trial of atropine vs. 
patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 
Mar 2002;120(3):268-278. 
37. Repka MX, Wallace DK, Beck RW, et al. Two-year follow-up of a 6-month 
randomized trial of atropine vs patching for treatment of moderate 
amblyopia in children. Arch Ophthalmol. Feb 2005;123(2):149-157. 
38. Holmes JM, Beck RW, Kraker RT, et al. Impact of patching and atropine 
treatment on the child and family in the amblyopia treatment study. Archives 
of Ophthalmology. 2003;121(11):1625-1632. 
39. Woldeyes A, Girma A. Profile of Amblyopia at the Pediatric Ophthalmology 
Clinic of Menilik II Hospital, Addis Ababa. Ethiop.J.Health Dev. 
2008;22(2):201-205. 
40. Holmes JM, Strauber S, Quinn GE, et al. Further validation of the Amblyopia 
Treatment Index parental questionnaire. Journal of Aapos: American 
Association for Pediatric Ophthalmology & Strabismus. 2008;12(6):581-584. 
41. Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral 
strabismic and mixed amblyopia using occlusion dose monitors to record 
compliance. Investigative Ophthalmology and Visual Science. April 
2005;46(4):1435-1439. 
42. Stewart CE, Moseley MJ, Stephens DA, Fielder AR. Treatment dose-response 
in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia 
Study (MOTAS). Invest Ophthalmol Vis Sci. Sep 2004;45(9):3048-3054. 
43. Loudon SE, Fronius M, Looman CW, et al. Predictors and a remedy for 
noncompliance with amblyopia therapy in children measured with the 
occlusion dose monitor. Investigative Ophthalmology & Visual Science. 
2006;47(10):4393-4400. 
44. Searle A, Norman P, Harrad R, Vedhara K. Psychosocial and clinical 







45. Dixon-Woods M, Awan M, Gottlob I. Why is compliance with occlusion 
therapy for amblyopia so hard? A qualitative study. Archives of Disease in 
Childhood. 2006;91(6):491-494. 
46. Newsham D. A randomised controlled trial of written information: the effect 
on parental non-concordance with occlusion therapy. British Journal of 
Ophthalmology. 2002;86(7):787-791. 
47. Tjiam AM, Holtslag G, Vukovic E, et al. An Educational Cartoon Accelerates 
Amblyopia Therapy and Improves Compliance, Especially among Children of 
Immigrants. Ophthalmology. Nov 2012;119(11):2393-2401. 
48. Tripathi A, O'Donnell NP, Holden R, Kaye L, Kaye SB. Occlusion therapy for 
the treatment of amblyopia: letting the parents decide. Ophthalmologica. 
2002;216(6):426-429. 
 
 
 
 
 
 
 
 
